Mother's epigenetic memory essential for embryo development and survival
14 July, 2017It has long been debated if epigenetic modifications accumulated throughout the entire life can cross the border of generations and be inherited by children or even grandchildren.
Gut flora an early marker for heart failure?
14 July, 2017In the gut of patients with heart failure, important groups of bacteria are found less frequently and the gut flora is not as diverse as in healthy individuals.
Gonorrhoea resistance on the rise; new drugs needed
07 July, 2017Each year around 78 million people are infected with gonorrhoea, a common sexually transmitted infection.
Personalised vaccine prompts strong anti-tumour response in patients
06 July, 2017A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumour cells has been shown to stimulate a potent, safe and highly specific immune anti-tumour response in melanoma patients, reported scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.
Australian-Canadian partnership for medical cannabis
04 July, 2017LeafCann Group, a Melbourne-based medical cannabis producer, has formed a joint venture with Canadian developer of medical cannabis delivery systems and devices Resolve Digital Health.
Skin cancer costs 30 times more to treat than prevent
03 July, 2017Despite being largely preventable, skin cancer costs Victoria's public hospitals more than $50 million a year, new research from Deakin University and Cancer Council Victoria has found.
Aus cancer vaccine closer to human trials
30 June, 2017Radvax, a cancer treatment vaccine, being developed by South Australian company Vaxine, is closer to human trials.
New approach examines how medicines act on cells
19 June, 2017Australian researchers have developed a new approach to monitor how medicines interact with and modify the activity of living cells.
'Turning off' allergies
05 June, 2017 by Adam FloranceResearchers are one step closer to a treatment that could 'turn off' the immune response that causes common allergies, including asthma — which affects over two million Australians.
Staying clinically competitive
05 June, 2017 by Mansi GandhiCost-competitiveness, high-quality data and fast study start-up times are some of the key factors that make Australia an attractive market for clinical trials. But as other countries strive to improve their clinical competitiveness, can Australia hold a dominant position?
Designer viruses to fight cancer
29 May, 2017Scientists have created designer viruses that alert the immune system and cause it to send killer cells to help fight cancer.
Putting brakes on cancer's ability to spread
29 May, 2017 by Phil SneidermanUS researchers have discovered a biochemical signalling process that causes densely packed cancer cells to break away from a tumour and spread the disease elsewhere in the body.
Australian researchers build brain-on-a-chip
15 May, 2017Australian researchers have grown brain cells on a semiconductor wafer patterned with nanowires which act as a scaffold to guide the growth of brain cells.
Jumping without slipping: the secret of the leafhopper
12 May, 2017UK researchers have uncovered the secret behind the explosive leaping ability of leafhopper insects — a discovery that could help create better technology in the future.
Cannabis could reverse brain decline
10 May, 2017Cannabis has the potential to reverse brain ageing and improve memory function, a new European study has revealed.
